{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T02:02:28Z","timestamp":1766023348704,"version":"3.48.0"},"reference-count":38,"publisher":"e-Century Publishing Corporation","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/gnsb4367","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T02:52:03Z","timestamp":1748573523000},"page":"3333-3344","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of the combined use of linaclotide and probiotics on clinical treatment efficacy and quality of life in patients with constipation-predominant irritable bowel syndrome"],"prefix":"10.62347","volume":"17","author":[{"given":"Yu","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.3390\/nu15071647","article-title":"Constipation-predominant irritable bowel syndrome (IBS-C): effects of different nutritional patterns on intestinal dysbiosis and symptoms","volume":"15","author":"Di Rosa","year":"2023","unstructured":"Di Rosa C, Altomare A, Terrigno V, Carbone F, Tack J, Cicala M and Guarino MPL. Constipation-predominant irritable bowel syndrome (IBS-C): effects of different nutritional patterns on intestinal dysbiosis and symptoms. Nutrients 2023; 15: 1647.","journal-title":"Nutrients"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12967-024-04898-1","article-title":"The gut microbiota participates in the effect of linaclotide in patients with irritable bowel syndrome with constipation (IBS-C): a multicenter, prospective, pre-post study","volume":"22","author":"Zhou","year":"2024","unstructured":"Zhou J, Wei H, Zhou A, Xiao X, Xie X, Tang B, Lin H, Tang L, Meng R, Yuan X, Zhang J, Huang C, Huang B, Liao X, Zhong T, He S, Gu S and Yang S. The gut microbiota participates in the effect of linaclotide in patients with irritable bowel syndrome with constipation (IBS-C): a multicenter, prospective, pre-post study. J Transl Med 2024; 22: 98.","journal-title":"J Transl Med"},{"key":"ref2","unstructured":"Curtis S and Curtis M. Tenapanor (Ibsrela) for the treatment of irritable bowel syndrome with constipation. Am Fam Physician 2022; 105: 656-658."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/ajg.2010.66","article-title":"Gastroduodenal disorders","volume":"105","author":"Tack","year":"2010","unstructured":"Tack J and Talley NJ. Gastroduodenal disorders. Am J Gastroenterol 2010; 105: 757-763.","journal-title":"Am J Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/jgh.12388","article-title":"Impact of parental-rearing styles on irritable bowel syndrome in adolescents: a school-based study","volume":"29","author":"Xing","year":"2014","unstructured":"Xing Z, Hou X, Zhou K, Qin D and Pan W. Impact of parental-rearing styles on irritable bowel syndrome in adolescents: a school-based study. J Gastroenterol Hepatol 2014; 29: 463-468.","journal-title":"J Gastroenterol Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"115064","DOI":"10.1016\/j.jep.2022.115064","article-title":"Mild moxibustion for irritable bowel syndrome with diarrhea (IBS-D): a randomized controlled trial","volume":"289","author":"Wang","year":"2022","unstructured":"Wang Z, Xu M, Shi Z, Bao C, Liu H, Zhou C, Yan Y, Wang C, Li G, Zhang W, Gao A and Wu H. Mild moxibustion for irritable bowel syndrome with diarrhea (IBS-D): a randomized controlled trial. J Ethnopharmacol 2022; 289: 115064.","journal-title":"J Ethnopharmacol"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Brenner DM, Harris LA, Chang CH, Waldman SA, Poppers DM, Kassebaum-Ladewski A and Sayuk GS. Real-world treatment strategies to improve outcomes in patients with chronic idiopathic constipation and irritable bowel syndrome with constipation. Am J Gastroenterol 2022; 117: S21-S26.","DOI":"10.14309\/ajg.0000000000001709"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.3390\/nu14122482","article-title":"Effectiveness and safety of probiotics for patients with constipation-predominant irritable bowel syndrome: a systematic review and meta-analysis of 10 randomized controlled trials","volume":"14","author":"Shang","year":"2022","unstructured":"Shang X, E FF, Guo KL, Li YF, Zhao HL, Wang Y, Chen N, Nian T, Yang CQ, Yang KH and Li XX. Effectiveness and safety of probiotics for patients with constipation-predominant irritable bowel syndrome: a systematic review and meta-analysis of 10 randomized controlled trials. Nutrients 2022; 14: 2482.","journal-title":"Nutrients"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ijsu.2020.04.063","article-title":"The efficacy and safety of probiotics for patients with constipation-predominant irritable bowel syndrome: a systematic review and meta-analysis based on seventeen randomized controlled trials","volume":"79","author":"Wen","year":"2020","unstructured":"Wen Y, Li J, Long Q, Yue CC, He B and Tang XG. The efficacy and safety of probiotics for patients with constipation-predominant irritable bowel syndrome: a systematic review and meta-analysis based on seventeen randomized controlled trials. Int J Surg 2020; 79: 111-119.","journal-title":"Int J Surg"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"17562848221092596","DOI":"10.1177\/17562848221092596","article-title":"Linaclotide for treating patients with irritable bowel syndrome with predominant constipation: a multicentre study of real-world data in China","volume":"15","author":"Liu","year":"2022","unstructured":"Liu L, Zhang W, Zhao W, Guo S, Wang Y, Lv X, Li B, Wang H, Xu E, Li Q, Zhu Q, Gou XB, Zhao W and Guo J. Linaclotide for treating patients with irritable bowel syndrome with predominant constipation: a multicentre study of real-world data in China. Therap Adv Gastroenterol 2022; 15: 17562848221092596.","journal-title":"Therap Adv Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"354","DOI":"10.14309\/ajg.0000000000000967","article-title":"Randomized trial of 2 delayed-release formulations of linaclotide in patients with irritable bowel syndrome with constipation","volume":"116","author":"Chey","year":"2021","unstructured":"Chey WD, Sayuk GS, Bartolini W, Reasner DS, Fox SM, Bochenek W, Boinpally R, Shea E, Tripp K and Borgstein N. Randomized trial of 2 delayed-release formulations of linaclotide in patients with irritable bowel syndrome with constipation. Am J Gastroenterol 2021; 116: 354-361.","journal-title":"Am J Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/1751-2980.13081","article-title":"Efficacy and safety of linaclotide in patients with irritable bowel syndrome with constipation: Chinese sub-cohort analysis of a phase III, randomized, double-blind, placebo-controlled trial","volume":"23","author":"Peng","year":"2022","unstructured":"Peng LH, Fang JY, Dai N, Shen XZ, Yang YL, Sun J and Yang YS. Efficacy and safety of linaclotide in patients with irritable bowel syndrome with constipation: Chinese sub-cohort analysis of a phase III, randomized, double-blind, placebo-controlled trial. J Dig Dis 2022; 23: 99-110.","journal-title":"J Dig Dis"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/jhn.13194","article-title":"Evaluation of the effects of the FODMAP diet and probiotics on irritable bowel syndrome (IBS) symptoms, quality of life and depression in women with IBS","volume":"37","author":"Ustao&#x11F","year":"2024","unstructured":"Ustaoğlu T, Tek NA and Yıldırım AE. Evaluation of the effects of the FODMAP diet and probiotics on irritable bowel syndrome (IBS) symptoms, quality of life and depression in women with IBS. J Hum Nutr Diet 2024; 37: 5-17.","journal-title":"J Hum Nutr Diet"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"BouSaba J, Sannaa W, McKinzie S, Vijayvargiya P, Chedid V, Wang XJ, Atieh J, Zheng T, Brandler J, Taylor AL, Busciglio I, Harmsen WS and Camilleri M. Impact of bile acid diarrhea in patients with diarrhea-predominant irritable bowel syndrome on symptoms and quality of life. Clin Gastroenterol Hepatol 2022; 20: 2083-2090, e2081.","DOI":"10.1016\/j.cgh.2021.11.035"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.neurom.2021.10.009","article-title":"Transcutaneous electrical acustimulation improved the quality of life in patients with diarrhea-irritable bowel syndrome","volume":"25","author":"Hu","year":"2022","unstructured":"Hu P, Sun K, Li H, Qi X, Gong J, Zhang Y, Xu L, Lin M, Fan Y and Chen JDZ. Transcutaneous electrical acustimulation improved the quality of life in patients with diarrhea-irritable bowel syndrome. Neuromodulation 2022; 25: 1165-1172.","journal-title":"Neuromodulation"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.2147\/JIR.S458363","article-title":"The neutrophil-to-albumin ratio (NAR): a novel index in relation to clinical symptoms, quality of life, and psychological status in diarrhea-predominant irritable bowel syndrome (IBS-D)","volume":"17","author":"Huang","year":"2024","unstructured":"Huang X, Li A, Long P, Liu Y, Zhou Z and Pan Y. The neutrophil-to-albumin ratio (NAR): a novel index in relation to clinical symptoms, quality of life, and psychological status in diarrhea-predominant irritable bowel syndrome (IBS-D). J Inflamm Res 2024; 17: 3685-3695.","journal-title":"J Inflamm Res"},{"key":"ref16","unstructured":"Liu Y and Liu JS. Chinese expert consensus of irritable bowel syndrome in 2020. Chinese Medical Journal 2021; 40: 803-818."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"625","DOI":"10.5056\/jnm19086","article-title":"Stool consistency: looking beyond the bristol stool form scale","volume":"25","author":"Vork","year":"2019","unstructured":"Vork L, Wilms E, Penders J and Jonkers DMAE. Stool consistency: looking beyond the bristol stool form scale. J Neurogastroenterol Motil 2019; 25: 625.","journal-title":"J Neurogastroenterol Motil"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1007\/s00464-019-06803-0","article-title":"Outcome of laparoscopic ventral mesh rectopexy for full-thickness external rectal prolapse: a systematic review, meta-analysis, and meta-regression analysis of the predictors for recurrence","volume":"33","author":"Emile","year":"2019","unstructured":"Emile SH, Elfeki H, Shalaby M, Sakr A, Sileri P and Wexner SD. Outcome of laparoscopic ventral mesh rectopexy for full-thickness external rectal prolapse: a systematic review, meta-analysis, and meta-regression analysis of the predictors for recurrence. Surg Endosc 2019; 33: 2444-2455.","journal-title":"Surg Endosc"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12888-019-2427-6","article-title":"Norms for Zung’s self-rating anxiety scale","volume":"20","author":"Dunstan","year":"2020","unstructured":"Dunstan DA and Scott N. Norms for Zung’s self-rating anxiety scale. BMC Psychiatry 2020; 20: 90.","journal-title":"BMC Psychiatry"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/02813432.2019.1639923","article-title":"Validation of the Zung self-rating depression scale (SDS) in older adults","volume":"37","author":"Jokelainen","year":"2019","unstructured":"Jokelainen J, Timonen M, Keinänen-Kiukaanniemi S, Härkönen P, Jurvelin H and Suija K. Validation of the Zung self-rating depression scale (SDS) in older adults. Scand J Prim Health Care 2019; 37: 353-357.","journal-title":"Scand J Prim Health Care"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Jansson-Knodell CL, White M, Lockett C, Xu H and Shin A. Associations of food intolerance with irritable bowel syndrome, psychological symptoms, and quality of life. Clin Gastroenterol Hepatol 2022; 20: 2121-2131, e2123.","DOI":"10.1016\/j.cgh.2021.12.021"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1046\/j.1365-2036.1997.142318000.x","article-title":"The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress","volume":"11","author":"CY","year":"1997","unstructured":"Francis CY, Morris J and Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997; 11: 395-402.","journal-title":"Aliment Pharmacol Ther"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"872","DOI":"10.14309\/ajg.0000000000002064","article-title":"Linaclotide reduced response time for irritable bowel syndrome with constipation symptoms: analysis of 4 randomized controlled trials","volume":"118","author":"Brenner","year":"2023","unstructured":"Brenner DM, Lacy BE, Ford AC, Bartolini W, Wu J, Shea EP, Bochenek W, Boinpally R and Almansa C. Linaclotide reduced response time for irritable bowel syndrome with constipation symptoms: analysis of 4 randomized controlled trials. Am J Gastroenterol 2023; 118: 872-879.","journal-title":"Am J Gastroenterol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1055\/a-1491-1784","article-title":"Effects of linaclotide in the treatment of chronic constipation and irritable bowel syndrome with constipation: a meta-analysis","volume":"60","author":"Zhao","year":"2022","unstructured":"Zhao Q, Fang Y, Yan C, Gao J, Liu Z, Zhu H, Tang D and Wang D. Effects of linaclotide in the treatment of chronic constipation and irritable bowel syndrome with constipation: a meta-analysis. Z Gastroenterol 2022; 60: 970-977.","journal-title":"Z Gastroenterol"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Fukudo S, Miwa H, Nakajima A, Haruma K, Kosako M, Nakagawa A, Akiho H, Yamaguchi Y, Johnston JM, Currie M and Kinoshita Y. A randomized controlled and long-term linaclotide study of irritable bowel syndrome with constipation patients in Japan. Neurogastroenterol Motil 2018; 30: e13444.","DOI":"10.1111\/nmo.13444"},{"key":"ref26","unstructured":"Shekhar H and Pradhan. Probiotics in IBS: a treatment boon or a pill bulk: RCT-based analysis. J Assoc Physicians India 2023; 71: 1."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.1097\/js9.0000000000000658","article-title":"Probiotics for the management of irritable bowel syndrome: a systematic review and three-level meta-analysis","volume":"109","author":"Chen","year":"2023","unstructured":"Chen M, Yuan L, Xie CR, Wang XY, Feng SJ, Xiao XY and Zheng H. Probiotics for the management of irritable bowel syndrome: a systematic review and three-level meta-analysis. Int J Surg 2023; 109: 3631-3647.","journal-title":"Int J Surg"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/apt.16437","article-title":"Systematic review and network meta-analysis: efficacy of licensed drugs for abdominal bloating in irritable bowel syndrome with constipation","volume":"54","author":"Nelson","year":"2021","unstructured":"Nelson AD, Black CJ, Houghton LA, Lugo-Fagundo NS, Lacy BE and Ford AC. Systematic review and network meta-analysis: efficacy of licensed drugs for abdominal bloating in irritable bowel syndrome with constipation. Aliment Pharmacol Ther 2021; 54: 98-108.","journal-title":"Aliment Pharmacol Ther"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Velez Lopez A, Waddell A, Antonacci S, Castillo D, Santucci N, Ollberding NJ, Eshleman EM, Denson LA and Alenghat T. Microbiota-derived butyrate dampens linaclotide stimulation of the guanylate cyclase C pathway in patient-derived colonoids. Neurogastroenterol Motil 2023; 35: e14681.","DOI":"10.1111\/nmo.14681"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"585","DOI":"10.51821\/84.4.009","article-title":"Clinical assessment and cytokines level in constipation-predominant irritable bowel syndrome participants treated with lactobacillus-containing cultured milk drink","volume":"84","author":"Mokhtar","year":"2021","unstructured":"Mokhtar NM, Jaafar NM, Alfian E, Mohd Rathi ND, Abdul Rani R and Raja Ali RA. Clinical assessment and cytokines level in constipation-predominant irritable bowel syndrome participants treated with lactobacillus-containing cultured milk drink. Acta Gastroenterol Belg 2021; 84: 585-591.","journal-title":"Acta Gastroenterol Belg"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Mearin F, Cortes X, Mackinnon J, Bertsch J, Fortea J and Tack J. Economic and quality-of-life burden of moderate-to-severe irritable bowel syndrome with constipation (Ibs-C) In Spain: the Ibis-C study. Value Health 2014; 17: A365.","DOI":"10.1016\/j.jval.2014.08.811"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.gastha.2023.02.009","article-title":"Comparison of quality of life and psychiatric symptoms between patients with diarrhea-predominant irritable bowel syndrome and those with constipation-predominant irritable bowel syndrome","volume":"2","author":"Bousaba","year":"2023","unstructured":"Bousaba J, Dilmaghani S, Taylor A, Busciglio I, McKinzie S and Camilleri M. Comparison of quality of life and psychiatric symptoms between patients with diarrhea-predominant irritable bowel syndrome and those with constipation-predominant irritable bowel syndrome. Gastro Hep Adv 2023; 2: 623-625.","journal-title":"Gastro Hep Adv"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"17667","DOI":"10.1038\/s41598-023-44493-w","article-title":"Age, quality of life and mental well-being in adolescent population: a network model tree analysis","volume":"13","author":"Cilar Budler","year":"2023","unstructured":"Cilar Budler L and Stiglic G. Age, quality of life and mental well-being in adolescent population: a network model tree analysis. Sci Rep 2023; 13: 17667.","journal-title":"Sci Rep"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1281457","DOI":"10.3389\/fpubh.2023.1281457","article-title":"Health-related quality of life of Korean older adults according to age, sex, and living arrangements: a cross-sectional study","volume":"11","author":"HA","year":"2023","unstructured":"Hwang HA, Jeong H and Yim HW. Health-related quality of life of Korean older adults according to age, sex, and living arrangements: a cross-sectional study. Front Public Health 2023; 11: 1281457.","journal-title":"Front Public Health"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1007\/s12325-022-02161-x","article-title":"Cost-effectiveness of linaclotide compared to osmotic laxatives in the treatment of irritable bowel syndrome with constipation in China","volume":"39","author":"Xiao","year":"2022","unstructured":"Xiao D, Zhang Y, Chen W, Xuan J and Chen Y. Cost-effectiveness of linaclotide compared to osmotic laxatives in the treatment of irritable bowel syndrome with constipation in China. Adv Ther 2022; 39: 2971-2983.","journal-title":"Adv Ther"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Rizal H, Said MA, Abdul Majid H, Su TT, Maw Pin T, Ismail R and Shah Zaidi MA. Health-related quality of life of younger and older lower-income households in Malaysia. PLoS One 2022; 17: e0263751.","DOI":"10.1371\/journal.pone.0263751"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Violato M, Pollard J, Lloyd A, Roope LSJ, Duch R, Becerra MF and Clarke PM. The COVID-19 pandemic and health-related quality of life across 13 high- and low-middle-income countries: a cross-sectional analysis. PLoS Med 2023; 20: e1004146.","DOI":"10.1371\/journal.pmed.1004146"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/5\/ajtr0159672.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:57:35Z","timestamp":1766023055000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/5\/ajtr0159672.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/gnsb4367","relation":{},"ISSN":["1943-8141"],"issn-type":[{"type":"electronic","value":"1943-8141"}],"subject":[],"published":{"date-parts":[[2025]]}}}